Pilot Bleeding Study: Risk and Protective Factors Associated With Bleeding in the Hemodialysis Population

NCT ID: NCT00182117

Last Updated: 2006-01-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

490 participants

Study Classification

OBSERVATIONAL

Study Start Date

2003-10-31

Study Completion Date

2006-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is examining the risk and protective factors associated with bleeding in the hemodialysis population.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bleeding End Stage Renal Disease

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

bleeding end stage renal disease antiplatelet therapy anticoagulant therapy hemodialysis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

DEFINED_POPULATION

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient is undergoing hemodialysis
Minimum Eligible Age

0 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

St. Joseph's Healthcare Hamilton

OTHER

Sponsor Role collaborator

Hamilton Health Sciences Corporation

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Christian G Rabbat, MD

Role: PRINCIPAL_INVESTIGATOR

Assistant Professor, Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

St. Joseph's Healthcare

Hamilton, Ontario, Canada

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Canada

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Christian G Rabbat, MD

Role: CONTACT

Phone: 905-522-1155

Email: [email protected]

Catherine M Clase, MD

Role: CONTACT

Phone: 905-522-1155

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Christian G Rabbat, MD

Role: primary

Catherine M Clase, MD

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Division of Nephrology Funds

Identifier Type: -

Identifier Source: org_study_id